Key facts
- This page summarizes Vida Ventures GP III, L.L.C.'s Form 4 filing for Vigil Neuroscience, Inc. (VIGL).
- 6 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 11 Jan 2022, 20:18.
Vida Ventures GP III, L.L.C. - 11 Jan 2022 Form 4 Insider Report for Vigil Neuroscience, Inc. (VIGL)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- VIGL
- Reported as of
- 11 Jan 2022
- Net transaction value
- +$23,450,000
- SEC form
- 4
- Accepted by SEC
- 11 Jan 2022, 20:18:09 UTC
- Prior SEC filing
- 06 Jan 2022
- Next SEC filing
- 10 Sep 2025
- Source filing
- View source filing
- Reporting owner signature
- VIDA VENTURES GP III, L.L.C., By: /s/ Stefan Vitorovic, its Managing Member
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Vida Ventures GP III, L.L.C. filed Form 4 for Vigil Neuroscience, Inc. (VIGL) on 11 Jan 2022.
Change
- Previous filing in this sequence was filed on 06 Jan 2022.
- Current net transaction value: +$23,450,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VIGL
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +3,333,245
- Change %
- Price
- Shares after
- 3,333,245
- Date
- 11 Jan 2022
- Ownership
- By Vida Ventures III, L.P.
- Footnotes
- F1, F2
VIGL
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +7,684
- Change %
- Price
- Shares after
- 7,684
- Date
- 11 Jan 2022
- Ownership
- By Vida Ventures III-A, L.P.
- Footnotes
- F1, F3
VIGL
transaction
Common Stock
Purchase
- Transaction value
- $23,396,072
- Shares
- +1,671,148
- Change %
- +50%
- Price
- $14.00
- Shares after
- 5,004,393
- Date
- 11 Jan 2022
- Ownership
- By Vida Ventures III, L.P.
- Footnotes
- F2, F4
VIGL
transaction
Common Stock
Purchase
- Transaction value
- $53,928
- Shares
- +3,852
- Change %
- +50%
- Price
- $14.00
- Shares after
- 11,536
- Date
- 11 Jan 2022
- Ownership
- By Vida Ventures III-A, L.P.
- Footnotes
- F3, F5
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
VIGL
transaction
Derivative
Series B Preferred Stock
Conversion of derivative security
- Transaction value
- $0
- Shares
- -9,243,756
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 11 Jan 2022
- Ownership
- By Vida Ventures III, L.P.
- Underlying class
- Common Stock
- Underlying amount
- 3,333,245
- Exercise price
- Footnotes
- F1, F2
VIGL
transaction
Derivative
Series B Preferred Stock
Conversion of derivative security
- Transaction value
- $0
- Shares
- -21,310
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 11 Jan 2022
- Ownership
- By Vida Ventures III-A, L.P.
- Underlying class
- Common Stock
- Underlying amount
- 7,684
- Exercise price
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Each share of Series B Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock") on a one-for-2.7732 basis upon the closing of the Issuer's initial public offering on January 11, 2022 and had no expiration date.
Footnote F2
The shares are held directly by Vida Ventures III, L.P. ("Vida III"). Vida Ventures GP III, L.L.C.("Vida III GP") is the general partner of Vida III. Vida III GP disclaims beneficial ownership of the securities held of record by Vida III, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their pecuniary interest therein, if any.
Footnote F3
The shares are held directly by Vida Ventures III-A, L.P. ("Vida III-A"). Vida III GP is the general partner of Vida III-A. Vida III GP disclaims beneficial ownership of the securities held of record by Vida III-A, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their pecuniary interest therein, if any.
Footnote F4
On January 11, 2022, Vida III purchased 1,671,148 shares of Common Stock of the Issuer at a price of $14.00 per share pursuant to an underwritten public offering.
Footnote F5
On January 11, 2022, Vida III-A purchased 3,852 shares of Common Stock of the Issuer at a price of $14.00 per share pursuant to an underwritten public offering.